Monday, June 8, 2015

The Role of Gastrointestinal Biofilm in Health and Disease with Stephen F. Olmstead, MD

Join us for The Role of Gastrointestinal Biofilm in Health and Disease with Stephen F. Olmstead, MD on Hawthorn’s Holistic Health and Nutrition Webinar Series, Tuesday June 16th, 2015 at 4 PM PST / 7 PM EST. This presentation will address the nature of microbial biofilms and take a deeper look at the advantages of life within biofilms associated with Helicobacter pylori infections and candidiasis sensitivity syndrome. Biofilms made by beneficial microbes contribute to normal gut and immune function while those produced by pathogens contribute to disease. Biofilm has an significant role in infections, and is integral to chronic and recurrent infections. Disruption of disease-associated biofilm using digestive and anti-inflammatory enzymes is an effective strategy to improve treatment outcomes for certain chronic and recurrent infectious disorders.

From this presentation attendees will:

-Achieve greater understanding of the nature and properties of biofilms;

-Understand the contribution of pathogenic biofilm to chronic and recurrent infections;

-Learn to disrupt pathogenic biofilm using antibiofilm enzymes.

Stephen F. Olmstead, MD, is Chief Science Officer at ProThera, Inc. where he directs clinical trials of ProThera® and Klaire Labs™ nutraceutical products. He received his MD from the University of New Mexico in 1979 and completed his Internal Medicine residency at Harvard Medical School, Massachusetts General Hospital in 1982 and fellowship in Cardiovascular Diseases at the University of Washington in 1987. His current research focuses on the use of enzymes and chelating agents to disrupt pathogenic GI biofilm and pre- and probiotics to restore gut microbial balance.

Join us early at 3:50 PM PST for the Announcements Segment and a brief interview with Dr. Olmsted.

RSVP Here:

Stephen Olmstead, MD